The Daily Stream: Andr The Giant Documentary Proves He Truly Was The Eighth Wonder Of The World – /Film

Thanks to the internet allowing a view into celebrity lives unlike ever before, Andr the Giant very well may be the last great folk hero. The image of Roussimoff was titanic in nature by virtue of his size, wearing 22 size shoes, with hands that could cover an adult man's entire face, and a towering height rumored to be 7'4" before his numerous back surgeries, but everything else about him was also notoriously huge. He could throw around the 6-foot-8 Big John Studd like nothing, could easily drink a case of wine as a pre-game warm-up, and was said to rip farts that could clear out a whole room. There was no such thing as "go big or go home," because when it comes to Andr the Giant, big is home.

Unfortunately, this meant that the circumstances which led to his colossal size were ignored. Roussimoff was born with acromegaly, a rare condition where the body produces too much growth hormone, causing body tissues and bones to grow more quickly. Not only did Andr spend much of his life in the physically demanding and taxing world of professional wrestling, but he had to travel without any proper accommodations. "It'd be like having to sit on baby furniture for your entire life," Hulk Hogan describes. As much as Andr was beloved the world over, he was also seen as a "freak of nature" by those who were unfamiliar with him. In the doc, "Mean" Gene Okerlund recounts a few touching instances where he confesses Andr would be brought to tears by some of the hurtful comments from strangers, but he'd never let the public see him cry.

Excerpt from:

The Daily Stream: Andr The Giant Documentary Proves He Truly Was The Eighth Wonder Of The World - /Film

Bring your empties to The Beer Store in Hawkesbury to support HGH Foundation – The Review Newspaper

The Hawkesbury and District General Hospital (HGH) Foundation and The Beer Store are inviting members of the community to bring empties to The Beer Store in Hawkesbury from now until August 28 to donate in support of their regional hospital.

The funds raised will help the HGH Foundation achieve its mission to improve the care and services offered by the Hawkesbury hospital. Support will allow the hospital to acquire state-of-the-art equipment needed to meet the health care needs of the community and will also help HGH develop new programs and services for thegrowing region. This will enable access to more specialty care, closer to hom for local patients and families.

Led by Store Manager, Kirk Manson, the staff at The Beer Stores Hawkesbury location is proud to organize this fundraiser to help support their regional hospital. Customers are invited to participate through monetary donations or donations of empty cans and bottles. The Beer Store in Hawkesbury is located at 1036 Lansdowne Street.

For the third year in a row, The Beer Store is proud to be part of a fundraiser for the Hawkesbury and District General Hospital Foundation. Collectively alongside our customers, we have raised close to $14,000 over the lifetime of this event, and we are hoping to beat that number this year! Manson said. We accept donations through empty returns, as well as cash donations at the registers. Stop by, come see us, and drop off some of your empties towards a great cause!

The HGH Foundation is very happy to be the beneficiary of this fundraiser once again this year, said Christine Gray-St-Denis. We are grateful to The Beer Store and its customers for their continuous support. Thank you for making a difference for our hospital!

View original post here:

Bring your empties to The Beer Store in Hawkesbury to support HGH Foundation - The Review Newspaper

Exhibitors report 30% higher biz at HGH India – The Hans India

Hyderabad: HGH India concluded its 11th edition at India Expo Centre, Greater Noida, with an all-time high business reported by over 70 per cent of the exhibitors.

Number of trade buyers across all four categories i.e. home textiles, home dcor, houseware and gifts too exceeded all previous editions, making a total of 37,260 visitors to HGH India 2022. Coming for sourcing from over 560 cities and towns, they clearly established the growing demand for high quality and branded home products even in the tier 2 and tier 3 cities and towns of India.

Most of the exhibitors reported a 25-30 per cent growth in the business as compared to previous editions which is a clear sign of markets becoming better. The growing demand for home products shows the pandemic effects are wearing off at the retail level.

Arun Roongta, MD, HGH India, said: "There is a visible spike in the penetration of the market which is getting deeper and wider. In these B towns, consumption of high quality home products is going up. Prosperity in the Indian economy with a growth rate of 7-8 per cent seems to be real and widely spread & is no longer restricted to the urban markets and the metro cities alone."

Follow this link:

Exhibitors report 30% higher biz at HGH India - The Hans India

Overview Panoramic Thermal Imaging Cameras Market 2022-2028 Business Analysis by Top Companies like Sierra Pacific Innovations, HGH, IRay Technology,…

The report provides an in-depth analysis of the Global Market of Panoramic Thermal Imaging Cameras. It presents the latest data of the market value, consumption, domestic production, exports and imports, and price dynamics. The Panoramic Thermal Imaging Cameras market report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of key factors influencing the market. Forecasts illustrate how the market will be transformed in the medium term. Profiles of the leading players like Sierra Pacific Innovations, HGH, IRay Technology, Axis Communications, Nippon Avionics, Pelco, etc. are also included.

Data Coverage in Panoramic Thermal Imaging Cameras Market Report are:

Get Premium Quality Sample copy of Panoramic Thermal Imaging Cameras Market Report at: https://www.affluencemarketreports.com/industry-analysis/request-sample/2584548/

The Key Players Covered in Panoramic Thermal Imaging Cameras Market Study are:

Segmentation Analysis:

Panoramic Thermal Imaging Cameras market is split by Type and by Application. For the period 2016-2028, the growth among segments provides accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market Segmentation by Type:

Market Segmentation by Applications:

For more Customization in this Report, Connect with us at https://www.affluencemarketreports.com/industry-analysis/request-inquiry/2584548/

The report offers valuable insight into the Panoramic Thermal Imaging Cameras market progress and approaches related to the Panoramic Thermal Imaging Cameras market with an analysis of each region. The report goes on to talk about the dominant aspects of the market and examine each segment.

The Panoramic Thermal Imaging Cameras market report gives CAGR value, Industry Chains, Upstream, Geography, End-user, Application, Competitor analysis, SWOT Analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends, and Forecast. The report also gives insight into the entry and exit barriers of the industry.

Global Panoramic Thermal Imaging Cameras Market Report Scope:

The report offers a complete company profiling of leading players competing in the global Panoramic Thermal Imaging Cameras market with a high focus on the share, gross margin, net profit, sales, product portfolio, new applications, recent developments, and several other factors. It also throws light on the vendor landscape to help players become aware of future competitive changes in the global Panoramic Thermal Imaging Cameras market.

Target Audience of the Global Panoramic Thermal Imaging Cameras Market in Market Study:

Get Extra Discount on Panoramic Thermal Imaging Cameras Market Report, If your Company is Listed in Above Key Players List @ https://www.affluencemarketreports.com/industry-analysis/request-discount/2584548/

Major Points from Table of Contents

For More Details on Impact of COVID-19 on Panoramic Thermal Imaging Cameras Market: https://www.affluencemarketreports.com/industry-analysis/covid19-request/2584548/

About Affluence:

Affluence Market Reports is the next generation of all your research needs with a strong grapple on the worldwide market for industries, organizations, and governments. Our aim is to deliver exemplary reports that meet the definite needs of clients, which offers an adequate business technique, planning, and competitive landscape for new and existing industries that will develop your business needs.

We provide a premium in-depth statistical approach, a 360-degree market view that includes detailed segmentation, key trends, strategic recommendations, growth figures, Cost Analysis, new progress, evolving technologies, and forecasts by authentic agencies.

For More Details Contact Us:

Affluence Market Reports

Contact Person: Mr. Rohit

Phone Number: U.S +1-(424) 256-1722

Email: [emailprotected]

Website: http://www.affluencemarketreports.com

Drop Cable Market 2022-2028 Strategical Assessment of Prysmian, Nexans, General Cable, Sumitomo Electric, Southwire, Furukawa Electric, and more | Affluence

Drone Ship Market: Industry Insights and Forecast 2022-2028 by Textron Systems, Rafael, Elbit Systems, Kongsberg Maritime, Liquid Robotics, Teledyne Marine, and more | Affluence

Drivetrain Industry: Growth Drivers by Top Players like GKN, BorgWarner, Dana Holding, Magtec, Delphi Automotive, Parker Hannifin, and more | Affluence

Driver ICs Market: Business Outlook 2022-2028 by Diodes, Analog Devices, Texas Instruments, Maxim Integrated, NXP, Infineon, and more | Affluence

Read this article:

Overview Panoramic Thermal Imaging Cameras Market 2022-2028 Business Analysis by Top Companies like Sierra Pacific Innovations, HGH, IRay Technology,...

From WBC to ANZ: Why are these NZX banking shares in news today? – Kalkine Media

The banking sector reported growth despite an economic slowdown in New Zealand. The big banks reported strong FY22 results. The big two banks also made significant announcements today, which are likely to have an impact on their businesses and bottom lines. Their respective shares were trading mixed on Monday.

Earlier, the banks were also impacted by the OCR hike delivered by the Reserve Bank of New Zealand (RBNZ). Last week, the central bank raised the OCR by 50 bps. Most economists are expecting a 50bps increase, lifting the total OCR to 2.5% from 2%.

Against this background, lets see how are some banking stocks doing.

Australia and New Zealand Banking Group Limited (NZX:ANZ,ASX:ANZ)

ANZ is one of the largest banks operating in New Zealand. The bank struck a deal with the Suncorp Group of Australia. According to the terms of the deal, Suncorp will be selling its banking arm to ANZ. The total transaction cost of the deal is to the tune of AU$4.9 billion. The deal is expected to give a boost to the retail and commercial business. The combination of ANZ and Suncorp is likely to make the joint entity stand third largest bank in household lending and household deposits, said the announcement on the NZX.

Suncorp has a large customer base in the home loan segment itself. The business is well established, especially in the home loan segment. According to the terms of the agreement, the CEO of Suncorp Van Clive will report to ANZs CEO. ANZ expects to complete the deal by the second half of CY2023.

On 18 July, the stock was trading flat at NZ$23.950, at the time of writing.

Heartland Group Holdings Limited (NZX:HGH)

HGH is an NZ-based financial services company of New Zealand. It operates through its banking subsidiary called Heartland Bank Limited. In June, HGH completed the acquisition of StockCo Australia. The acquisition is for a total consideration of AU$154.4 million. It is expected to expand HGHs product offerings in Australia with the help of StockCo.

The Company reported strong growth in its FY22 half-yearly results. The NPAT grew 7.8%. The interim dividend announced by the company was 5.5 cps in 1HFY22, up from 1.5 cps in 1HFY21.

On 18 July, the stock was trading up 1.49% at NZ$2.040, at the time of writing.

Westpac Banking Corporation(NZX:WBC)

Westpac is a top bank of New Zealand with headquarters in Sydney, Australia. The bank has been highly profitable due to lending activity. In the first six months of FY22, it made profits to the tune of NZ$635 partly due to the sale of its insurance arm. Its loan book was up 4% to NZ$94 billion and its mortgage lending activity was also up 7% to NZ$62.2 billion. It paid a dividend of 61 cps with 8 cps as imputed credits. The dividend was paid on 27 June.

On 18 July, the stock was trading up 2.53% to NZ$22.25, at the time of writing.

Bottom Line: Banking stocks have done major acquisitions to enhance their businesses and increase the spread and the product portfolio.

Read more:

From WBC to ANZ: Why are these NZX banking shares in news today? - Kalkine Media

Beard Growth: Tips to Speed Up the Process – Medical News Today

Although exercising and eating a nutritious diet may speed up beard growth, the main factors that determine how fully a persons beard will grow are hormones and genetics.

Males start to grow facial hair during puberty. Many of them will notice that their facial hair first begins to grow on the upper lip.

Other areas people may notice early facial hair growth include the chin or the sides of the face near the ears, which people refer to as sideburns.

Facial hair grows differently for everyone. Some individuals may be able to grow a full beard during late stage or even middle stage adolescence. Others may continue to have sparse areas of growth until their late 20s, while some may never experience significant facial hair growth.

This article will explore what factors influence a persons beard growth and whether it is possible for someone to make their beard grow faster.

Genetics and hormones are the main factors that determine how quickly and fully a persons beard will grow. Their lifestyle and habits may also affect how their beard grows.

Testosterone is a hormone that affects the growth of facial hair, and its levels can vary. Males between 19 and 38 typically have a range of 264 to 916 nanograms per deciliter. This represents the 2.5th to 97.5th percentile for testosterone.

Low testosterone can adversely affect beard growth. For males with low testosterone, taking supplements under a doctors supervision may help increase beard growth.

If a persons testosterone levels fall within typical ranges, taking supplements will most likely not affect their beard growth.

Genetics also affect the way a persons beard grows. Some genes make them more prone to growing a fuller beard, while others may only ever be able to grow a sparse or patchy beard or other facial hair.

The health and well-being of a person affect how their whole body functions, including how their beard grows. Even though it is not possible to alter someones genes, lifestyle habits they can adopt may help them achieve a fuller beard.

Exercise improves blood flow, which helps stimulate hair follicle growth. Exercises, such as weightlifting and strength training, may also help boost a persons testosterone levels.

During the day, testosterone levels naturally fluctuate in young males, with a higher level in the morning and a lower level in the afternoon.

Good nutrition from eating a balanced diet may help in growing a beard and staying healthy.

According to a 2015 study, obesity and low testosterone have a bidirectional relationship, meaning that low testosterone can lead to obesity and obesity can lead to low testosterone.

Nutrients, such as zinc, may also be beneficial for testosterone levels. A nutritious diet will not override genetics, but it may help the existing hair grow healthier and fuller. Some foods that can help include:

Some supplements can contribute toward maintaining a persons health in a way that is conducive to growing their beard as fully as their genetic makeup will allow.

A person may wish to take a multivitamin containing iron and zinc if their diet does not provide them with sufficient amounts of these nutrients.

However, there are no supplements that will enable a person to grow a beard if they do not have the genes to do so.

Maintaining a healthy skin care routine, including keeping the beard clean, can positively affect how a persons beard will grow and look.

Exfoliating the face can help remove dead skin cells and debris from around each hair follicle, allowing the hair to grow through the skin unimpeded. Exfoliating can also reduce ingrown hairs under the beard.

Leave-in conditioners for beards can nourish the hair and keep it moisturized. This helps reduce and prevent beard dandruff and makes the beard look fuller. It is best to perform a patch test to find out which products work best for the beard.

As well as being necessary for overall health, sleep can also aid beard growth.

The testosterone levels in males generally increase when they are asleep. A 2015 study found that reducing the amount of daily sleep lowered testosterone levels in healthy young males.

Keeping a beard clean and moisturized can help it appear thicker. However, there is no certain routine with scientific backing that can thicken a growing beard.

However, some anecdotal evidence suggests that olive oil and avocado oil could thicken beards.

It is possible that these may work the way leave-in conditioners do by keeping the beard nourished and moisturized.

Growing a beard depends mostly on a persons genetics.

However, testosterone plays some role in determining how fast and well someones beard will grow.

Making sure to keep testosterone levels within a stable, healthy range by regularly exercising, eating well, getting sufficient, restful sleep, and exfoliating can help a persons beard grow as thick and full as it is naturally able.

Continue reading here:

Beard Growth: Tips to Speed Up the Process - Medical News Today

Shrink Your Belly After 50 With This Total-body Workout, Trainer Says Eat This Not That – Eat This, Not That

Losing belly fat can be a grueling process, and unfortunately, it gets more difficult once you hit 50 and up. As you age, your body endures many changes. You lose lean muscle mass, and hormones like melatonin, estrogen, testosterone, and growth hormone decrease. That's why it's crucial to stay active and consistent with strength training. Needless to say, if you want to shrink your belly after 50, the key is to incorporate full-body strength training workouts into your fitness regimen.

Muscle is your fountain of youth, as it keeps your metabolism up and helps you stay lean. So we've put together an effective total-body workout that will sculpt muscle, burn calories, and be a major player in your belly fat loss journey. Read on to learn more about this routine, and get ready to shrink your belly. And next up, don't miss The 6 Best Exercises for Strong and Toned Arms in 2022, Trainer Says.

For this exercise, you're going to stand in front of the kettlebell with your feet outside of the weight. Push your hips back, and squat down low enough to grab the kettlebell. Make sure your shoulders are in line with the handle and your torso is straight. Keep your core tight and shoulders down, and pick up the kettlebell by pushing through your heels and hips. Stand up tall, and flex your glutes at the top. Reverse the motion to put the weight down before performing another rep. Complete 3 sets of 10 reps.6254a4d1642c605c54bf1cab17d50f1e

Related: The #1 Workout To Lose Your Beer Gut for Good, Trainer Says

Grab a single dumbbell and hold it up to your shoulders with your feet shoulder-width distance apart. Keeping your chest tall and core tight, press the weight all the way up until your arm is fully extended, flexing your tricep and shoulder at the top. Lower under control until back to the starting position before performing another rep. Complete 3 sets of 10 to 12 reps on each arm.

To perform the Bodyweight Row, grab the equipment that's available to you. It can be rings (as I have here), a bar, or a TRX/suspension strap. If you're using a strap, make sure to use a neutral grip (palms facing you). If you have a bar, either use the pronated (palms overhand) or supinated (underhand) grip.

Stick your feet forward, and lean back slightly to at least 45 degrees. Keeping your core tight and hips high, pull yourself in by driving with your elbows towards your hips. Squeeze your lats and upper back hard to finish, then straighten your arms fully until your shoulder blades stretch at the bottom before performing another rep. Perform 3 sets of 12 to 15 reps.

Related: Get a Flatter Stomach With These Quick Daily Exercises, Trainer Says

Start the movement by holding a pair of dumbbells with your feet shoulder-width distance apart. Keeping your chest tall, step out to the side while pushing your hips back. Let the trailing leg lengthen, stretching the inner thigh. Push yourself back to the starting position with the heel of the working leg before stepping out to the other side. Complete 3 sets of 10 reps on each leg.

Tim Liu, C.S.C.S.

Read the original post:

Shrink Your Belly After 50 With This Total-body Workout, Trainer Says Eat This Not That - Eat This, Not That

The #1 Fastest Way to Look Younger, Says Science Eat This Not That – Eat This, Not That

All the cosmetic surgery in the world can't undo the damage of an unhealthy lifestyle, but adapting just a few health habits can turn back the clockboth on the outside and the inside. Here are five things that will make you look younger, according to experts. Read onand to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID.

Protecting your skin from the sun can take years off your face, experts say. "Sun exposure depletes collagen, which keeps the skin smooth and firm," says dermatologist E. Victor Ross, MD. "It can dilate blood vessels to give skin a red tone. And it causes the brown pigment in the skin to be more pronounced, which can make the skin look blotchy. It also creates something called elastotic material, which creates a cobblestone appearance in the skin."

Managing stress in a healthy manner not only helps you look younger, it can prevent premature aging on a cellular level. "While stressful, a moment of stress here and there isn't problematic. It's the chronic, long-term stress that can wear our bodies down and lead to premature aging," says Mona Brownfield, MD. "Research has found the hormones produced with chronic stress can age our brain and immune systems. Those who are constantly stressed have higher instances of dementia and memory loss, as well as more damaged cells within their immune systems. Stress also lends itself to high blood pressure, making you more susceptible to heart disease and other conditions typically found in older populations."6254a4d1642c605c54bf1cab17d50f1e

Not only does exercise give your skin an incredible youthful glow, it encourages anti-aging on a cellular level. "Running allows your muscles to behave like much more youthful muscles," says Justus Ortega, Ph.D., a professor of kinesiology and the director of the Biomechanics Lab at Humboldt State University. "It's this crazy trickle-down effect. If you're able to keep your mitochondria in a more healthy state through running, that allows you to be more active in all the other aspects of your life, and that can help to stave off all the things that we typically see with agingheart disease, diabetes, obesity, bone loss."

Smoking is terrible for your health, and terrible for your skin. "Smoking can speed up the normal aging process of your skin, contributing to wrinkles and other changes to the appearance of your face," says J. Taylor Hays, M.D. "These changes include crow's-feet, pronounced lines between the eyebrows, uneven skin complexion, a grayish tone on lighter skin, deep creases and puffiness below the eyes, wrinkles around the mouth, and thinner lips The damage to your skin from smoking can't be reversed. But if you quit smoking now, you will no longer accelerate the problem and may prevent worsening of the damage."

It's called "beauty sleep" for a reasongetting enough sleep can take years off your appearance. "Human growth hormone (HGH) has its highest production during slow-wave sleep," says Shelby Freedman Harris, Psy.D. "HGH is a key player in keeping us looking young even after we've finished growing. HGH is produced by the pituitary gland and is in high levels during childhood and adolescence. After we've grown, HGH levels drop off and stay at low, steady levels during adulthood. Deficiencies in HGH can lead to reduced muscle mass, slower metabolism, more belly fat and sagging skin. Sleep more, and you'll likely increase your HGH levels."

Ferozan Mast

Read the original:

The #1 Fastest Way to Look Younger, Says Science Eat This Not That - Eat This, Not That

Rani Therapeutics (NASDAQ:RANI) and Indivior (OTCMKTS:INVVY) Head to Head Survey – Defense World

Rani Therapeutics (NASDAQ:RANI Get Rating) and Indivior (OTCMKTS:INVVY Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Rani Therapeutics and Indivior, as reported by MarketBeat.com.

Institutional & Insider Ownership

2.3% of Rani Therapeutics shares are held by institutional investors. 52.3% of Rani Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Rani Therapeutics and Indiviors net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Rani Therapeutics and Indiviors top-line revenue, earnings per share (EPS) and valuation.

Indivior has higher revenue and earnings than Rani Therapeutics. Rani Therapeutics is trading at a lower price-to-earnings ratio than Indivior, indicating that it is currently the more affordable of the two stocks.

Summary

Indivior beats Rani Therapeutics on 7 of the 13 factors compared between the two stocks.

Rani Therapeutics Company Profile (Get Rating)

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.

Indivior Company Profile (Get Rating)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Receive News & Ratings for Rani Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rani Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

See the rest here:

Rani Therapeutics (NASDAQ:RANI) and Indivior (OTCMKTS:INVVY) Head to Head Survey - Defense World

Soleno Therapeutics Announces Presentation of DCCR Data at the 11th International Prader-Willi Syndrome Organisation Conference – BioSpace

REDWOOD CITY, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics , Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced presentations at the 11th International Prader-Willi Syndrome Organisation (IPWSO) Conference, held on July 6-10, 2022, in Limerick, Ireland.

The presentations by Mr. Pittman and Ms. Bolding included the results from the analysis of caregiver interviews conducted after at least 12 months of investigational, open-label DCCR treatment. The interviews were available for 51 patients who were enrolled in the DCCR Phase 3 program. Casimir Inc (Casimir) completed semi-structured interviews with these participants and interview transcripts were manually coded by trained coders who subsequently analyzed the coded interviews in accordance with a pre-specified statistical analysis plan. Folia Health used the Casimir-prepared transcripts and conducted a semi-automated analysis using Natural Language Processing (NLP) methods.

In the Casimir analysis, 33 (65%), 30 (59%), and 31 (61%) caregivers described a positive change in food-related behavior, non-food-related behavior, and daily life, respectively. Of these, 26 (51%), 20 (39%), and 25 (49%), respectively, reported a positive change with major impact. The analysis was based on thematic coding of 12-month interview data by trained, blinded researchers.

The Folia Health NLP analysis of interview transcripts identified seven problematic behavior domains.88% of participants experienced positive change in at least one behavior with DCCR treatment. Positive change was detected across all seven identified domains, most commonly in food seeking (72%) and daily life (73%).

Both analyses of caregiver interviews presented at IPWSO summarize the positive changes across all seven identified behavioral domains, in both food- and non-food-related behaviors, as well as daily life, while receiving long-term DCCR. These findings, combined with the totality of data generated in our DCCR program, continue to support the potential DCCR has to be a safe and tolerable therapy that may provide meaningful benefit to people with PWS, caregivers, and families, saidAnish Bhatnagar, M.D., Chief Executive Officer ofSoleno Therapeutics.

The presentations by Dr. Miller and Dr. Strong consisted largely of data presented at prior meetings.

About PWSThe Prader-Willi Syndrome Association USAestimates that PWS occurs in one in every 15,000 live births in theU.S.The hallmark symptom of this disorder is hyperphagia, a chronic feeling of insatiable hunger that severely diminishes the quality of life for PWS patients and their families. Additional characteristics of PWS include behavioral problems, cognitive disabilities, low muscle tone, short stature (when not treated with growth hormone), the accumulation of excess body fat, developmental delays, and incomplete sexual development. Hyperphagia can lead to significant morbidities (e.g., obesity, diabetes, cardiovascular disease) and mortality (e.g., stomach rupture, choking, accidental death due to food seeking behavior). In a global survey conducted by theFoundation for Prader-Willi Research, 96.5% of respondents (parent and caregivers) rated hyperphagia and 92.9 % body composition as the most important or a very important symptom to be relieved by a new medicine. There are currently no approved therapies to treat the hyperphagia/appetite, metabolic, cognitive function, or behavioral aspects of the disorder. Diazoxide choline has received Orphan Drug Designation for the treatment of PWS in theU.S.and E.U., and Fast Track Designation in theU.S.

About DCCR (Diazoxide Choline) Extended-Release TabletsDCCR is a novel, proprietary extended-release dosage form containing the crystalline salt of diazoxide and is administered once-daily. The parent molecule, diazoxide, has been used for decades in thousands of patients in a few rare diseases in neonates, infants, children and adults, but has not been approved for use in PWS. Soleno conceived of and established extensive patent protection on the therapeutic use of diazoxide and DCCR in patients with PWS. The DCCR development program is supported by data from five completed Phase 1 clinical studies in healthy volunteers and three completed Phase 2 clinical studies, one of which was in PWS patients. In the PWS Phase 3 study, DCCR showed promise in addressing hyperphagia, the hallmark symptom of PWS, as well as several other symptoms such as aggressive/destructive behaviors, fat mass and other metabolic parameters.

AboutSoleno Therapeutics, Inc.Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The companys lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase 3 clinical development program. For more information, please visit http://www.soleno.life.

About Folia HealthFolia is a patient-driven Health-IOS (Individual Operating System) that enables individuals to easily take an active role in their care, while contributing to precision diagnostics, patient-centered drug development, & better care for complex diseases. Folias rich longitudinal data and proprietary analytic methods provide a vital and missing piece in the emergence of a home-centered, data-driven healthcare ecosystem. Discover how to harness the power of patient and caregiver knowledge at http://www.foliahealth.com.

About CasimirCasimir is a Contract Research Organization (CRO) that develops novel outcomes for decentralized and hybrid trials in order to better understand disease progression and treatment benefit.Casimir was recently acquired by Emmes, a global full-service CRO dedicated to excellence in supporting the advancement of public health and biopharmaceutical innovation. To learn more about how our research is making a positive impact on human health, visitwww.emmes.com.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements, including statements regarding timing of any regulatory process or ultimate approvals and determining a path forward for DCCR for the treatment of PWS. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, including the risks and uncertainties associated with market conditions, as well as risks and uncertainties inherent in Solenos business, including those described in the company's prior press releases and in the periodic reports it files with theSEC. The events and circumstances reflected in the company's forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, the company does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Corporate Contact:Brian RitchieLifeSci Advisors, LLC212-915-2578

Go here to see the original:

Soleno Therapeutics Announces Presentation of DCCR Data at the 11th International Prader-Willi Syndrome Organisation Conference - BioSpace